A rating scale for mania: reliability, validity and sensitivity
about
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode networkContextual social cognition impairments in schizophrenia and bipolar disorderThe cognitive impact of the ANK3 risk variant for bipolar disorder: initial evidence of selectivity to signal detection during sustained attentionMethylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Cognitive–behavioral therapy for bipolar disorderCaregiver Burden in Bipolar Hypomania and Mania: A Systematic ReviewBipolar Depression in Pediatric PopulationsValproate for acute mood episodes in bipolar disorderLifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replicationAntipsychotic medications for cocaine dependenceAtypical antipsychotics for psychosis in adolescentsPsychosocial interventions for people with both severe mental illness and substance misusePharmacotherapy for bipolar disorder in older peopleAdjunctive antioxidants for bipolar disorderTiagabine for acute affective episodes in bipolar disorderOxcarbazepine for acute affective episodes in bipolar disorderEarly intervention for psychosisPsychosocial interventions for people with both severe mental illness and substance misuseOmega-3 fatty acids for bipolar disorderInterventions for helping people recognise early signs of recurrence in bipolar disorderEarly Intervention for psychosisOlanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnessesTopiramate for acute affective episodes in bipolar disorderTiagabine in the treatment of acute affective episodes in bipolar disorderInterventions for helping people recognise early signs of recurrence in bipolar disorderRegulation of glycogen synthase kinase-3 during bipolar mania treatmentEfficacy of antimanic treatments: meta-analysis of randomized, controlled trialsA Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderSensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar typeAdjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label studyEarly-onset bipolar spectrum disorders: diagnostic issuesRevisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionBipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy studyDetection of prodromal symptoms of relapse in mania & unipolar depression by relatives & patientsThe schizophrenia phenotype in 22q11 deletion syndromeVisual hallucinations in maniaPediatric bipolar disorder: evidence for prodromal states and early markersAmisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial
P2860
Q21131813-C2E573B3-6D14-4AC8-AC76-21E81B7CA2A4Q21559683-5C203831-4CBE-4991-9694-11261AE5E504Q21560854-66B44EBF-86C2-4F2D-A50B-57286CC2404CQ22061981-D5BE7169-0E33-425F-956A-A7312DB85C8DQ22241478-C006A38F-211F-4E8C-9318-E83F89966DEFQ22242312-00C586A9-B96B-43AA-BE96-7EDB71BA48A5Q22252565-E85444CF-B875-4D05-8B51-7D9956B77321Q22252976-50DD2371-DFDF-48CF-A1AD-4E670FEEA56FQ22253024-2D224DD0-71FC-46D0-8474-08F5FA56B6A3Q24186021-E72A395A-669F-4F1C-83C5-3A55F31BC6F0Q24197475-C7D717DC-21DC-4F8A-A1CB-622644173A54Q24197576-AC8131C7-A581-4145-980D-E90BA96E2564Q24198086-F6B4599A-6D74-48D2-BF3E-444176534A43Q24198987-8F12141F-5979-4434-8F54-C8D234DE2B29Q24202532-37E114C7-A6B3-42BB-A8C7-0579A64794C8Q24234152-F468BC02-649A-4881-B123-74FD6F917A54Q24236296-1F2A18C8-EE74-499C-B202-5567B9DB3599Q24242339-16C78C25-FDA2-468A-9C07-F5D584B4DE37Q24243168-B6EB07B3-3E9A-4AD6-A750-CA373CD28054Q24243177-D06FB033-6183-4E6C-B46A-148AA25116FDQ24243986-948FBAD0-DCC4-4787-9AB0-49FD0147BB5AQ24244015-EAE3BF8F-F2DC-461E-9983-0BA3CA14B147Q24244960-6E9C04FC-8332-4382-BE55-50F9AEB42183Q24244993-A1513A53-A6AD-4AEB-8D45-81300F7B0D73Q24246887-A53FF14C-02CC-42DC-915A-2F02FEAC6A90Q24594534-3C08A759-087D-44C6-B8A0-00E944E2128FQ24601815-E4F3A0BE-224E-4A9F-9960-A1566F50BDAAQ24602988-E47FAB89-812F-4ABE-A28D-396CD689498BQ24605278-D2231872-31ED-4209-808B-535900B4CF29Q24619584-AD5E926C-938C-47D8-BDF6-DDEB9F816B65Q24619731-E472E91D-4ED5-4530-B998-2A5A40396DE0Q24621858-E7A1FF86-9681-4232-AA8B-1C42E3C137F9Q24629398-ED8A850B-7F6F-493C-A223-C20C3D0AA10FQ24630153-C536353D-1B19-4944-9AB3-E5FF206A0DD4Q24630222-28D934F0-7543-428D-903B-8A6217325F1AQ24633153-DD201DAB-4527-4044-A351-7D401B7B8CE7Q24633796-40C44370-5D09-4058-AFCC-2357421ACE82Q24634996-03E6D8DF-27DC-41ED-BB4D-0E2D1FE7CD16Q24635320-D18CDF7D-37B8-4615-8061-0F41AD8A94ECQ24656287-C6AA7082-DDFD-4C49-B737-640709CEED01
P2860
A rating scale for mania: reliability, validity and sensitivity
description
1978 nî lūn-bûn
@nan
1978 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
A rating scale for mania: reliability, validity and sensitivity
@ast
A rating scale for mania: reliability, validity and sensitivity
@en
type
label
A rating scale for mania: reliability, validity and sensitivity
@ast
A rating scale for mania: reliability, validity and sensitivity
@en
prefLabel
A rating scale for mania: reliability, validity and sensitivity
@ast
A rating scale for mania: reliability, validity and sensitivity
@en
P2093
P3181
P356
P1476
A rating scale for mania: reliability, validity and sensitivity
@en
P2093
P304
P3181
P356
10.1192/BJP.133.5.429
P407
P577
1978-11-01T00:00:00Z